2.2. NAB2::STAT6 fusion assessment

KE Kathryn L Eschbacher
QT Quynh T Tran
EM Evgeny A Moskalev
SJ Sarah Jenkins
KF Karen Fritchie
RS Robert Stoehr
AC Alissa Caron
ML Michael J Link
PB Paul D Brown
AG Andrew Guajardo
DB Daniel J Brat
AW Ashley Wu
SS Sandro Santagata
DL David N Louis
PB Priscilla K Brastianos
AK Alexander B Kaplan
BA Brian Alexander
SR Sabrina Rossi
FF Fabio Ferrarese
DR David R Raleigh
MN Minh P Nguyen
JG John Gross
JV Jose Velazquez Vega
FR Fausto Rodriguez
AP Arie Perry
ask Ask a question
Favorite

NAB2::STAT6 fusion status was successfully assessed in n = 101 cases, as previously described [1]. In brief, RNA extraction was performed using the Qiagen miRNeasy FFPE kit by methods previously described by Wang et al. [20]. Screening of the most common NAB2::STAT6 fusions was performed, including exon 4::exon 2, exon 4::exon 3, exon 6::exon 16, and exon 6::exon 17 using single‐plex PCR with subsequent agarose gel electrophoresis, identifying NAB2::STAT6 gene fusions. Samples with no results by single‐plex PCRs were analyzed by next‐generation sequencing using the Archer FusionPlex Sarcoma Kit (Archer Dx Inc, Boulder, CO) to detect fusions of 26 genes employing the Anchored Multiplex PCR‐based enrichment.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A